Bibliography

Found 816 results
2017
Xu Z, Asahchop EL, Branton WG, Gelman B, Power C, Hobman TC. MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology. PLoS Pathog. 2017 ;13(6):e1006360.
Wyczechowska D, Lin H-Y, LaPlante A, Jeansonne D, Lassak A, Parsons CH, Molina PE, Peruzzi F. A miRNA Signature for Cognitive Deficits and Alcohol Use Disorder in Persons Living with HIV/AIDS. [Internet]. 2017 ;10:385. Available from: https://www.frontiersin.org/article/10.3389/fnmol.2017.00385
Xing Y, Shepherd N, Lan J, Li W, Rane S, Gupta SK, Zhang S, Dong J, Yu Q. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders. Brain Behav Immun. 2017 .
Roda WC, Li MY, Akinwumi MS, Asahchop EL, Gelman B, Witwer KW, Power C. Modeling brain lentiviral infections during antiretroviral therapy in AIDS. J Neurovirol. 2017 ;23(4):577-586.
Shapshak P, Levine AJ, Foley BT, Somboonwit C, Singer EJ, Chiappelli F, Sinnott JT, Soontornniyomkij V. Neuropathology of HIV-1 disease. In: Global Virology II - HIV and NeuroAIDS. 1st ed. Global Virology II - HIV and NeuroAIDS. Springer; 2017. pp. 143-208.
Sanfilippo C, Pinzone MR, Cambria D, Longo A, Palumbo M, Di Marco R, Condorelli F, Nunnari G, Malaguarnera L, Di Rosa M. OAS Gene Family Expression Is Associated with HIV-Related Neurocognitive Disorders. Mol Neurobiol. 2017 .
Singer EJ, Nemanim N. The Persistence of HIV-Associated Neurocognitive Disorder (HAND) in the Era of Combined Antiretroviral Therapy (cART). In: Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS. Springer; 2017. pp. 375-403.
Bryant AK, Moore DJ, Burdo TH, Lakritz JR, Gouaux B, Soontornniyomkij V, Achim C, Masliah E, Grant I, Levine AJ, et al. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 ;31(7):973-979.
Levine AJ, Martin EM, Sacktor N, Munro C, Becker JT. Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders. JAIDS Journal of Acquired Immune Deficiency Syndromes [Internet]. 2017 ;75(2). Available from: http://journals.lww.com/jaids/Fulltext/2017/06010/Predictors_and_Impact_of_Self_Reported_Suboptimal.9.aspx
Malik S, Eugenin EA. Role of Connexin and Pannexin containing channels in HIV infection and NeuroAIDS. Neurosci Lett. 2017 .
Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons JL, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, et al. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 ;75(2):246-255.
Okafo G, Prevedel L, Eugenin E. Tunneling nanotubes (TNT) mediate long-range gap junctional communication: Implications for HIV cell to cell spread. Scientific Reports. 2017 ;7(1).
Robinson-Papp J, Navis A, Dhamoon MS, Clark US, Gutierrez-Contreras J, Morgello S. The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection. J Neuroimaging. 2017 .
2016
Saing T, Lagman M, Castrillon J, Gutierrez E, Guilford FT, Venketaraman V. Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process. BBA Clinical. 2016 ;6:38-44.
Dever SM, Rodriguez M, El-Hage N. B-Adrenergic receptor gene expression in HIV-associate neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. Journal of Neurovirology. 2016 .
Gutierrez J, Honig L, Elkind MSV, Mohr JP, Goldman JE, Dwork AJ, Morgello S, Marshall RS. Brain arterial aging and its relationship to Alzheimer Dementia. Neurology. 2016 ;86(16):1507-1515.
Gutierrez J, Menshawy K, Gonzalez M, Elkind MSV, Marshall RS, Dwork AJ, Morgello S. Brain large artery inflammation associated with human immunodeficiency virus and large artery remodeling. AIDS. 2016 ;30(3):415-423.
Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I. Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models. J Neuroimmune Pharmacol. 2016 ;11(3):495-510.
Fields J, Serger E, Campos S, Divakaruni AS, Kim C, Smith K, Trejo M, Adame A, Spencer B, Rockenstein E, et al. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiol Dis. 2016 ;86:154-69.
Lamers SL, Rose R, Maidji E, Agsalda-Garcia M, Nolan DJ, Fogel GB, Salemi M, Garcia DL, Bracci P, Yong WH, et al. HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads. Journal of Virology. 2016 ;90(20):8968-8983.
Li G-H, Lee MH, Major E, Nath A. HIV infection of astrocytes is detected in vivo by RNAscope and occurs in vitro via a non-classical mechanism. 2016 .
Rose R, Lamers SL, Nolan DJ, Maidji E, Faria NR, Pybus OG, Dollar JJ, Maruniak SA, McAvoy AC, Salemi M, et al. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer. Journal of Virology. 2016 ;90(20):8984-8993.
Avdoshina V, Fields J, Castellano P, Dedoni S, Palchik G, Trejo M, Adame A, Rockenstein E, Eugenin EA, Masliah E, et al. The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons. Neurotox Res. 2016 ;29(4):583-93.
Fan Y, He JJ. HIV-1 Tat induces unfolded protein response and endoplasmic reticulum stress in astrocytes and causes neurotoxicity through glial fibrillary acidic protein (GFAP) activation and aggregation. Journal of Biological Chemistry. 2016 ;291(43):22819-22829.
Berman JW, Carvallo L, Buckner CM, Luers A, Prevedel L, Bennett MV, Eugenin EA. HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS. J Neuroinflammation. 2016 ;13(1):54.

Pages